NanoViricides
NNVC
#10585
Rank
โ‚น3.21 B
Marketcap
โ‚น125.81
Share price
-0.76%
Change (1 day)
4.23%
Change (1 year)

NanoViricides (NNVC) - Total assets

Total assets on the balance sheet as of March 2026 : โ‚น0.98 Billion

According to NanoViricides's latest financial reports the company's total assets are โ‚น0.98 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

NanoViricides - Total assets on balance sheet (from 2006 to 2026)

Total assets by year

Year Total assets Change
2025-06-30โ‚น0.75 B-29.25%
2024-06-30โ‚น1.06 B-22.92%
2023-06-30โ‚น1.38 B-25.25%
2022-06-30โ‚น1.85 B-17.57%
2021-06-30โ‚น2.25 B24.24%
2020-06-30โ‚น1.81 B95.39%
2019-06-30โ‚น0.92 B-26.96%
2018-06-30โ‚น1.26 B-27.25%
2017-06-30โ‚น1.74 B-29.44%
2016-06-30โ‚น2.47 B-12%
2015-06-30โ‚น2.80 B6.83%
2014-06-30โ‚น2.63 B169.31%
2013-06-30โ‚น0.97 B12.57%
2012-06-30โ‚น0.86 B80.86%
2011-06-30โ‚น0.47 B14.95%
2010-06-30โ‚น0.41 B190.59%
2009-06-30โ‚น0.14 B127.9%
2008-06-30โ‚น63.01 M15.15%
2007-06-30โ‚น54.72 M-56.73%
2006-06-30โ‚น0.12 B
2005-06-30N/A

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
โ‚น4.777 T 482,941.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น12.562 T 1,270,102.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น8.481 T 857,459.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น7.917 T 800,437.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚น92.48 B 9,250.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น53.98 B 5,358.96%๐Ÿ‡บ๐Ÿ‡ธ USA